Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
- PMID: 23204124
- PMCID: PMC9487229
- DOI: 10.1183/09059180.00002512
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown aetiology. It is a rare disease, and its incidence and prevalence are not clear. Therefore, we sought to review the published evidence on the global epidemiology of IPF. A comprehensive review of English language literature was performed by searching Medline and EMBASE for studies on IPF epidemiology published between January 1990 and August 2011. Studies providing quantitative data on IPF incidence and/or prevalence were identified and key data collected. 15 studies reporting on the incidence and/or prevalence of IPF were identified and summarised. IPF prevalence estimates in the USA varied between 14 and 27.9 cases per 100,000 population using narrow case definitions, and 42.7 and 63 per 100,000 population using broad case definitions. In Europe, IPF prevalence ranged from 1.25 to 23.4 cases per 100,000 population. The annual incidence of IPF in the USA was estimated at 6.8-8.8 per 100,000 population using narrow case definitions and 16.3-17.4 per 100,000 population using broad case definitions. In Europe, the annual incidence ranged between 0.22 and 7.4 per 100,000 population. IPF prevalence and incidence increase with age, are higher among males and appear to be on the increase in recent years. IPF is an orphan disease that affects a potentially increasing number of people in Europe and the USA. The observed variability in IPF incidence and prevalence may be explained by the differences in diagnostic criteria used, case definition, study population and study design.
Conflict of interest statement
L. Nalysnyk was an employee of United BioSource Corporation at the time of study submission; he is now an employee of Genzyme Corporation. Genzyme Corporation had no involvement in the study. J. Cid-Ruzafa and P. Rotella are employees of United BioSource Corporation. D. Esser is an employee of Boehringer Ingelheim.
Figures
Similar articles
-
Global incidence and prevalence of idiopathic pulmonary fibrosis.Respir Res. 2021 Jul 7;22(1):197. doi: 10.1186/s12931-021-01791-z. Respir Res. 2021. PMID: 34233665 Free PMC article. Review.
-
Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.Ann Am Thorac Soc. 2022 Jul;19(7):1112-1121. doi: 10.1513/AnnalsATS.202102-222OC. Ann Am Thorac Soc. 2022. PMID: 35015982 Free PMC article.
-
Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.Int J Tuberc Lung Dis. 2016 Jul;20(7):978-84. doi: 10.5588/ijtld.16.0003. Int J Tuberc Lung Dis. 2016. PMID: 27287654
-
Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis.Respir Res. 2022 Feb 8;23(1):24. doi: 10.1186/s12931-022-01938-6. Respir Res. 2022. PMID: 35135550 Free PMC article.
-
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey.Adv Ther. 2021 Feb;38(2):854-867. doi: 10.1007/s12325-020-01578-6. Epub 2020 Dec 14. Adv Ther. 2021. PMID: 33315170 Free PMC article. Review.
Cited by
-
Determination of loss of chromosome Y in peripheral blood cells in males with idiopathic pulmonary fibrosis.Eur Respir J. 2024 Nov 14;64(5):2401303. doi: 10.1183/13993003.01303-2024. Print 2024 Nov. Eur Respir J. 2024. PMID: 39362669 Free PMC article.
-
The incidence of acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.Sci Rep. 2024 Sep 10;14(1):21080. doi: 10.1038/s41598-024-71845-x. Sci Rep. 2024. PMID: 39256473 Free PMC article.
-
Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis.BMC Pulm Med. 2024 Jul 31;24(1):373. doi: 10.1186/s12890-024-03188-2. BMC Pulm Med. 2024. PMID: 39085811 Free PMC article.
-
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.Pharmaceuticals (Basel). 2024 Jul 11;17(7):930. doi: 10.3390/ph17070930. Pharmaceuticals (Basel). 2024. PMID: 39065780 Free PMC article.
-
Patient Perception of Cough in Interstitial Lung Disease; Impact of Cough Hypersensitivity.Lung. 2024 Aug;202(4):425-430. doi: 10.1007/s00408-024-00723-0. Epub 2024 Jul 8. Lung. 2024. PMID: 38977494 Free PMC article.
References
-
- King TE, Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378: 1949–1961. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
